AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESRRA | Estrogen-related receptor alpha | Nuclear receptors Transcription factors
| | | | | Expressed in all |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
NR1H2 | Nuclear receptor subfamily 1, group H, member 2 | Cancer-related genes Nuclear receptors Transcription factors
| | | | | Expressed in all |
NR2C1 | Nuclear receptor subfamily 2, group C, member 1 | Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR2C2 | Nuclear receptor subfamily 2, group C, member 2 | Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | Nuclear receptors Transcription factors
| | | | | Expressed in all |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Group enriched |
RARA | Retinoic acid receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Mixed |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RORA | RAR-related orphan receptor A | Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RXRA | Retinoid X receptor, alpha | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
RXRB | Retinoid X receptor, beta | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
THRA | Thyroid hormone receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |